Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland

Study to evaluate the frequency of complete pathologic response after neo-adjuvant treatment with cisplatin chemotherapy in women with breast cancer and a BRCA1 mutation.

eCancer TV | November 25, 2009

Tags:. .cisplatin. .adjuvant. .pathologic. .jacek. .mutation